Log in  First Connection? Edition EN | FR

Archives   News of the month

Diseases: Chikungunya | Cholera | Dengue Fever | Diphteria | Hepatitis A | Hepatitis B | Japanese Encephalitis | Lyme Disease | Malaria | Rabies | Tick Borne Encephalitis (TBE) | Travellers Diarrhea | Typhoid | Yellow Fever | Zika | 
Categories: Editorial | Experts Opinions | Congress Highlights

 Hepatitis B
Diagnostic performance of hepatitis C virus core antigen testing for detecting hepatitis C in people living with hepatitis B: a systematic review and meta-analysis

Published on 07/01/2025 |  Original article (Abstract)  | Treviño-Nakoura Ana et al. | Infectious Diseases of Poverty 2024; 13(1): 89 6 min.

Viral hepatitis, particularly caused by the hepatitis B virus (HBV) and hepatitis C virus (HCV), remains a significant global health burden with increasing mortality rates [1]. Chronic hepatitis, predominantly attributed to HBV and HCV, is a leading cause of liver-related deaths. HCV/HBV coinfection...

Abstract Order article

 Hepatitis B
Immunization status and factors influencing hepatitis B vaccination of preterm infants in three provinces of China, 2019 to 2021

Published on 03/12/2024 |  Original article (Abstract)  | Huang Li-fang et al. | BMC Infectious Diseases 2024; 24(1): 942 5 min.

Hepatitis B is a serious infectious disease caused by hepatitis B virus (HBV) and is a global public health problem. China has a moderate prevalence of hepatitis B [1], with an estimated 70 million people living with HBV in 2017 and an overall population prevalence of 5%-6% [2]. To achieve the goal of...

Abstract Order article

 Hepatitis B
Identification of associated risk factors for serological distribution of hepatitis B virus via machine learning models

Published on 20/08/2024 |  Original article (Abstract)  | Yao Ning et al. | BMC Infectious Diseases 2023; 24(1): 66 5 min.

The viral hepatitis pandemic has become a heavy toll on lives and a great burden on communities and health systems worldwide. It accounts for over 1.4 million deaths annually due to acute infection and related hepatic carcinoma and cirrhosis [1]. Hepatitis B virus (HBV) is the most frequent cause...

Abstract Order article

 Hepatitis B
Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic?

Published on 20/08/2024 |  Original article (Abstract)  | Arslan, Eyup et al. | European Journal of Gastroenterology & Hepatology 2024; 36(4): 438-44 5 min.

Chronic hepatitis B (CHB) is a worldwide major public health problem, leading to progressive liver disease through chronic inflammation and destruction of hepatocytes. Hepatitis B virus (HBV) infection can lead to serious complications such as cirrhosis, liver failure, and hepatocellular carcinoma (HCC)...

Abstract Order article

 Hepatitis B
Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration of Maternal Screening and Infant Post-vaccination Serologic Testing

Published on 20/08/2024 |  Original article (Abstract)  | Wei-Ju Su et al. | Clinical infectious diseases 2024; 79(3): 690-700 4 min.

Evaluation of the impact on mother-to-child transmission (MTCT) of a HBV-prevention program that incorporates maternal antiviral prophylaxis is hindered by the limited availability of real-world data. This study analyzed data on maternal HBV screening, neonatal immunization, and post-vaccination serologic...

Abstract Order article